DarioHealth (DRIO)
(Delayed Data from NSDQ)
$0.93 USD
+0.02 (2.10%)
Updated Aug 23, 2024 03:58 PM ET
After-Market: $0.92 -0.01 (-1.02%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for DarioHealth Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -59.43 | -62.19 | -76.76 | -29.45 | -17.74 |
Depreciation/Amortization & Depletion | 4.99 | 4.72 | 4.67 | 0.19 | 0.18 |
Net Change from Assets/Liabilities | 3.83 | -11.40 | -3.29 | 0.42 | -0.43 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 20.23 | 21.03 | 24.97 | 11.10 | 2.26 |
Net Cash From Operating Activities | -30.38 | -47.85 | -50.41 | -17.74 | -15.73 |
Property & Equipment | -0.58 | -0.44 | -0.26 | -0.12 | -0.10 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -5.00 | 0.00 | 0.00 |
Investments | 0.04 | 0.00 | 0.00 | 0.00 | -0.02 |
Other Investing Activities | 0.00 | -0.13 | -2.88 | -1.50 | 0.00 |
Net Cash from Investing Activities | -0.55 | -0.57 | -8.13 | -1.62 | -0.11 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 16.48 | 38.15 | 65.77 | 27.55 | 25.25 |
Issuance (Repayment) of Debt | 1.77 | 23.79 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 18.25 | 61.94 | 65.77 | 27.55 | 25.25 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -12.67 | 13.52 | 7.22 | 8.19 | 9.41 |
Cash at Beginning of Period | 49.47 | 35.95 | 28.73 | 20.54 | 11.13 |
Cash at End of Period | 36.80 | 49.47 | 35.95 | 28.73 | 20.54 |
Diluted Net EPS | -1.93 | -2.54 | -4.07 | -4.01 | -8.00 |
Fiscal Year End for DarioHealth Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.79 | -7.18 | -59.43 | -45.14 | -29.41 |
Depreciation/Amortization & Depletion | 3.16 | 1.33 | 4.99 | 3.89 | 2.43 |
Net Change from Assets/Liabilities | -4.83 | -4.86 | 3.83 | 1.64 | 0.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -2.02 | -2.41 | 20.23 | 16.57 | 11.65 |
Net Cash From Operating Activities | -24.47 | -13.11 | -30.38 | -23.04 | -14.39 |
Property & Equipment | -0.09 | -0.06 | -0.58 | -0.50 | -0.22 |
Acquisition/ Disposition of Subsidiaries | -8.80 | -8.80 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -8.88 | -8.85 | -0.55 | -0.46 | -0.18 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 20.21 | 20.21 | 16.48 | 16.48 | 16.28 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 1.77 | 1.77 | 1.77 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 20.21 | 20.21 | 18.25 | 18.25 | 18.05 |
Effect of Exchange Rate Changes | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -13.20 | -1.76 | -12.67 | -5.25 | 3.47 |
Cash at Beginning of Period | 36.80 | 36.80 | 49.47 | 49.47 | 49.47 |
Cash at End of Period | 23.60 | 35.04 | 36.80 | 44.22 | 52.94 |
Diluted Net EPS | -0.08 | -0.20 | -0.41 | -0.49 | -0.58 |